Results of AIEOP LNH-97 protocol for the treatment of anaplastic large cell lymphoma of childhood

Marta Pillon, Fabiana Gregucci, Alessandra Lombardi, Nicola Santoro, Matilde Piglione, Alessandra Sala, Emanuele S G D'Amore, Raffaela De Santis, Fiorina Casale, Marco Zecca, Lara Mussolin, Angelo Rosolen

Research output: Contribution to journalArticlepeer-review


Background: Anaplastic large cell lymphoma (ALCL) represents approximately 15% of all pediatric non-Hodgkin lymphomas (NHL). It has distinct clinical features, including frequent involvement of extranodal sites and rare localization to the central nervous system (CNS). Despite varying treatment approaches the outcome of patients with ALCL has not significantly improved during the last two decades. Procedure: From October 1997 to beginning of 2000, newly diagnosed ALCL patients were enrolled into AIEOP LNH-97 protocol for ALCL. Thereafter and until 2007, only CNS positive patients were included. AIEOP LNH-97 was based on the BFM-95 schema for ALCL and included six high-dose chemotherapy courses. CNS prophylaxis was obtained with one intrathecal injection of chemotherapy in each course, whereas treatment of CNS involvement included three intrathecal injections without irradiation. Results: Thirty-two patients were eligible for the study. Lymph-node disease was the most frequent localization (69% of the cases), followed by mediastinal (25%), CNS (22%), bone marrow (16%), and skin (13%) involvement. Probabilities of overall survival (OS) and of event-free survival (EFS) at 5 years for the whole population were 87% (SE 6%) and 68% (SE 8%), respectively. Conclusions: This study confirmed that short pulse chemotherapy is an efficacious treatment option for first line therapy of pediatric ALCL, and that dose intensity may have some relevance for outcome, but not in all of the patients. Refinement and optimization of therapy strategies for ALCL may originate from a combination of clinical and biological prospective studies, as those in the pipeline of current international collaboration.

Original languageEnglish
Pages (from-to)828-833
Number of pages6
JournalPediatric Blood and Cancer
Issue number5
Publication statusPublished - Nov 2012


  • ALCL
  • Child
  • Clinical trials
  • Non-Hodgkin lymphoma
  • Outcome

ASJC Scopus subject areas

  • Oncology
  • Pediatrics, Perinatology, and Child Health
  • Hematology


Dive into the research topics of 'Results of AIEOP LNH-97 protocol for the treatment of anaplastic large cell lymphoma of childhood'. Together they form a unique fingerprint.

Cite this